🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Alignment Healthcare president Maroney sells over $144k in stock

Published 03/21/2024, 05:04 PM
© Reuters.
ALHC
-

Alignment Healthcare, Inc. (NASDAQ:ALHC) President of Markets, Dawn Christine Maroney, recently sold a significant amount of company stock, transactions that totaled over $144,000. The sales took place on March 19 and March 20, with Maroney disposing of 15,861 and 13,252 shares, respectively.

The shares were sold at weighted-average prices, with individual transactions occurring within a price range of $4.83 to $5.58 per share. The total proceeds from the sales on the two dates amounted to approximately $144,117. It should be noted that these transactions were executed to cover tax withholding obligations related to the grant of immediately vested common stock acquired on March 13, 2024, and are not considered discretionary trades by Maroney.

Following the transactions, Maroney's stake in the company stands at 1,986,248 shares of common stock. The sales were made public through a Form 4 filing with the Securities and Exchange Commission, which provides transparency on the trading activities of a company's insiders.

Investors often keep a close eye on insider transactions as they can provide valuable insights into the company's health and the confidence that executives have in the firm's future prospects. Alignment Healthcare, Inc., which specializes in hospital and medical service plans, continues to be a notable player in the healthcare sector.

For those interested in the company's stock performance and insider transactions, further details can be obtained from the company's filings and public disclosures.

InvestingPro Insights

As investors digest the recent insider transactions at Alignment Healthcare, Inc. (NASDAQ:ALHC), it's important to consider the company's financial health and market performance. According to InvestingPro data, Alignment Healthcare holds a market capitalization of $916.54 million USD. Despite a notable revenue growth of 27.16% over the last twelve months as of Q4 2023, the company's current P/E Ratio stands at -6.15, reflecting that it is not currently profitable.

One of the InvestingPro Tips highlights that Alignment Healthcare is trading at a low revenue valuation multiple, which could be of interest to value investors seeking potential growth opportunities. Additionally, the company holds more cash than debt on its balance sheet, which can be a positive sign of financial stability. However, analysts do not anticipate the company will be profitable this year, and the stock has fared poorly over the last month, with a price total return of -25.27%.

These insights, along with a broader array of InvestingPro Tips available on the product's website, can provide a deeper understanding of the company's financial position and future outlook. For those looking to explore these metrics further, there are additional tips listed on InvestingPro. To access these resources and enhance your investment analysis, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.